Radiation Basics - Tiny Rays, Big Concerns
- Ionizing Radiation: High energy; removes electrons from atoms, causing ionization.
- Types: Alpha ($\alpha$), Beta ($\beta$), Gamma ($\gamma$), X-rays, Neutrons.
- Sources:
- Natural: Radon (major contributor), cosmic rays, terrestrial (soil/rocks).
- Man-made: Medical (X-rays, CT scans, radiotherapy), industrial, nuclear fallout.
- Key Units:
- Absorbed Dose: Gray (Gy). Energy deposited/mass. (1 Gy = 100 rad).
- Equivalent Dose: Sievert (Sv). $H = D \times W_R$ (Radiation Weighting Factor). (1 Sv = 100 rem).
- Effective Dose: Sievert (Sv). $E = \sum_T (W_T \times H_T)$ (Tissue Weighting Factor).

⭐ Radon gas is the largest natural source of radiation exposure for the general public, contributing significantly to background radiation levels globally.
Biological Effects - Growing Bodies, Greater Risks
- Children: ↑ vulnerability due to rapid cell division, longer lifespan for effects to manifest.
- Effects:
- Deterministic: Dose-dependent, threshold exists (e.g., skin burns, cataracts). Severity ↑ with dose.
- Stochastic: Probability-dependent, no threshold (e.g., cancer, genetic effects). Probability ↑ with dose.
- Highly Radiosensitive Tissues: Bone marrow, thyroid, gonads, lens, developing brain, breast.
- Influencing Factors: Age (younger ↑risk), dose, dose rate, radiation type.

⭐ Children have a 2-3 times higher lifetime risk of developing radiation-induced solid cancers compared to adults exposed to the same dose.
Clinical Features - Sickness Spectrum
- Acute Radiation Syndrome (ARS): Dose-dependent, progresses through distinct phases.
- ARS Syndromes (Manifest Illness Phase):
- Hematopoietic (Bone Marrow) Syndrome: 1-6 Gy. Lymphopenia (early indicator), pancytopenia. ↑Infection, hemorrhage.
- Gastrointestinal (GI) Syndrome: 6-10 Gy. Severe N/V/D, mucosal denudation, dehydration, sepsis. Often fatal.
- Neurovascular/CNS Syndrome: >10 Gy (often >20 Gy). Rapid onset: ataxia, seizures, coma. Uniformly fatal.
- Chronic Effects:
- Carcinogenesis (leukemia, thyroid, solid tumors), genetic mutations, cataracts, pediatric growth retardation.
⭐ Lymphocyte count drop within 24-48 hours is a key early biological dosimeter for exposure severity.

Diagnosis & Management - Action Plan Alpha
- Triage & Decontaminate: Secure scene, ABCs. Remove clothes, wash skin. Consider internal decorporation.
- Estimate Dose (Biodosimetry): Lymphocyte kinetics (nadir at ~48h), dicentric chromosomes.
- Supportive Care: Fluids, antiemetics, infection prophylaxis if ANC < 500/µL.
- Management Flowchart:
- Specific Agents: KI (thyroid block), Prussian Blue (Cs, Tl), DTPA (transuranics), G-CSF (neutropenia).
- Follow-up: Monitor for ARS, late effects.
⭐ Absolute lymphocyte count at 48h is a key prognosticator for Acute Radiation Syndrome (ARS).
Prevention & Protection - Kid-Safe Shielding
- 📌 ALARA Principle: As Low As Reasonably Achievable.
- Core Principles:
- ↓ Time: Minimize exposure duration.
- ↑ Distance: Maximize distance from source.
- Shielding: Use lead aprons, thyroid/gonadal shields.
- Pediatric Focus:
- Always use child-sized shielding.
- Effective immobilization to prevent repeat exposures.
- Justify all radiologic procedures.
- Prefer USG/MRI when possible.
- Nuclear Emergencies:
- Potassium Iodide (KI) for thyroid gland protection.

- Potassium Iodide (KI) for thyroid gland protection.
⭐ Children have ↑ radiosensitivity (cells rapidly divide) & longer life expectancy for stochastic effects to manifest; 2-10x more sensitive than adults.
High-Yield Points - ⚡ Biggest Takeaways
- Children exhibit ↑ radiosensitivity; ALARA principle (As Low As Reasonably Achievable) is crucial in pediatric imaging.
- Deterministic effects (e.g., skin erythema, epilation) are dose-dependent with a threshold.
- Stochastic effects (e.g., malignancy, genetic changes) are probabilistic, with no threshold.
- Thyroid cancer is a significant concern post-exposure; Potassium Iodide (KI) for thyroid blocking.
- Acute Radiation Syndrome (ARS) phases: prodromal, latent, manifest illness, and recovery/death.
- Fetal radiation: highest risk during organogenesis (2-15 weeks gestation); doses < 50 mGy generally not linked to deterministic effects in utero.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app